Pulmonary infection due to Mycobacterium xenopi. 1994

T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
Department of Medicine, School of Medicine, Keio University, Tokyo.

We describe two cases of pulmonary infection due to Mycobacterium xenopi (M. xenopi). Both cases were men, ages 61 and 54 yr. In the first patient, lung infection due to M. xenopi occurred after gastrectomy. The second patient had an inactive M. tuberculosis infection. Both had pulmonary symptoms including cough, sputum and fever. Each chest X-ray showed an infiltrative shadow with a cavity in a unilateral, upper lobe. Isolates from both patients were studied not only by microbiological characteristics but also by DNA-DNA hybridization. All isolates were susceptible to streptomycin and kanamycin. In the first case, the patient had initially received rifampicin, isoniazid and ethambutol despite in vitro susceptibility patterns, however, there was no response and a new infiltrative shadow appeared in the contralateral lobe. With a multiple drug regimen based on in vitro susceptibility, clinical and roentgenographic improvements were achieved. The second patient showed a favorable response to the initial chemotherapy. Pulmonary infection due to M. xenopi can generally be successfully treated with drugs to which the organisms show in vitro sensitivity. We also reviewed the other two cases reported in Japan.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009164 Mycobacterium Infections Infections with bacteria of the genus MYCOBACTERIUM. Infections, Mycobacterium,Infection, Mycobacterium,Mycobacterium Infection
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D003523 Cycloserine Antibiotic substance produced by Streptomyces garyphalus. R-4-Amino-3-isoxazolidinone,Seromycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005743 Gastrectomy Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed) Gastrectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
January 2022, Access microbiology,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
March 2022, Infectious medicine,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
February 2003, The American journal of medicine,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
December 2001, The Annals of thoracic surgery,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
January 1998, Journal of computer assisted tomography,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
August 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
July 1982, European journal of respiratory diseases,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
April 1973, Annales de medecine interne,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
June 1975, Tubercle,
T Terashima, and F Sakamaki, and N Hasegawa, and M Kanazawa, and T Kawashiro
January 2007, Wiener klinische Wochenschrift,
Copied contents to your clipboard!